In Chapter 3, “The Enemy of Our Enemy Is Our Friend: Infecting the Infection,” author Emily Monosson makes the case for bacteriophage therapy in the treatment of infectious disease.
At Harvard University the chemical biologist looks for new metabolic pathways to investigate how gut bacteria interact with one another and their hosts.
Meet Scientist to Watch Emily Balskus, who studies the microbes that inhabit humans.
Two research teams develop tools for tinkering with a bacterial genus prominent in human guts.
Two new techniques allow researchers to manipulate the activity of gut bacteria.
Researchers develop a method that combines the strengths of shotgun metagenomics and single-cell genome sequencing in a microfluidics-based platform.
The discovery of peptides, enzymes, and other gene products that confer antibiotic resistance could give clues to how it develops.
Numerous scientists are disappointed with the American Society for Microbiology’s decision, and some are hatching plans to keep the meetings alive.
Advances in microbiome research are increasingly used in anti-vaccination arguments, yet the science actually undermines the premise of the argument.
Lactobacillus parafarraginis metabolites hindered the growth of multiple, distantly related bacterial pathogens.
The nationwide experiment will initially include around 100,000 volunteers.
After implantation, the tissue developed blood vessels and became integrated into neuronal networks in the animals’ brains.
Researchers deliver small interfering RNAs loaded into nanoparticles into the ears of adult guinea pigs to regenerate hair cells damaged by noise.
The US Senate narrowly approved the politician, who does not have a science background.
© 1986-2018 The Scientist
